| Item Type | Name |
|
Grant
|
Development of New Therapeutics for Pancreatic Cancer Management
|
|
Grant
|
GROWTH FACTOR RECEPTOR DIRECTED THERAPY IN CANCER
|
|
Grant
|
NEW ENDOCRINE THERAPY IN OLDER WOMEN WITH BREAST CANCER
|
|
Grant
|
(2/2) CDU/UCLA Cancer Center Partnership to Eliminate Cancer Health Disparities
|
|
Academic Article
|
HER-2 tyrosine kinase pathway targets estrogen receptor and promotes hormone-independent growth in human breast cancer cells.
|
|
Academic Article
|
Membrane-associated binding sites for estrogen contribute to growth regulation of human breast cancer cells.
|
|
Academic Article
|
Rational combinations of trastuzumab with chemotherapeutic drugs used in the treatment of breast cancer.
|
|
Academic Article
|
Antibody to HER-2/neu receptor blocks DNA repair after cisplatin in human breast and ovarian cancer cells.
|
|
Academic Article
|
Estrogen receptors outside the nucleus in breast cancer.
|
|
Academic Article
|
Membrane-associated estrogen receptor signaling pathways in human cancers.
|
|
Academic Article
|
Elevated serum cathepsin B1 and vaginal pathology after prenatal DES exposure.
|
|
Academic Article
|
A83-01 inhibits TGF-ß-induced upregulation of Wnt3 and epithelial to mesenchymal transition in HER2-overexpressing breast cancer cells.
|
|
Academic Article
|
Aromatase inhibitors combined with aspirin to prevent lung cancer in preclinical models.
|
|
Academic Article
|
Squalamine blocks tumor-associated angiogenesis and growth of human breast cancer cells with or without HER-2/neu overexpression.
|
|
Academic Article
|
Lysosomal cathepsin B-like activity: mobilization in prereplicative and neoplastic epithelial cells.
|
|
Academic Article
|
Remission of human breast cancer xenografts on therapy with humanized monoclonal antibody to HER-2 receptor and DNA-reactive drugs.
|
|
Academic Article
|
Monoclonal antibody to HER-2/neureceptor modulates repair of radiation-induced DNA damage and enhances radiosensitivity of human breast cancer cells overexpressing this oncogene.
|
|
Academic Article
|
Inhibitory effects of combinations of HER-2/neu antibody and chemotherapeutic agents used for treatment of human breast cancers.
|
|
Academic Article
|
Biologic effects of heregulin/neu differentiation factor on normal and malignant human breast and ovarian epithelial cells.
|
|
Academic Article
|
Interactions between estrogen and growth factor receptors in human breast cancers and the tumor-associated vasculature.
|
|
Academic Article
|
Estrogen receptors and cell signaling.
|
|
Academic Article
|
Biological characteristics of the pure antiestrogen fulvestrant: overcoming endocrine resistance.
|
|
Academic Article
|
Aromatase inhibitors in human lung cancer therapy.
|
|
Academic Article
|
Usefulness of 3'-[F-18]fluoro-3'-deoxythymidine with positron emission tomography in predicting breast cancer response to therapy.
|
|
Academic Article
|
Estrogen receptors in membrane lipid rafts and signal transduction in breast cancer.
|
|
Academic Article
|
Rational management of endocrine resistance in breast cancer: a comprehensive review of estrogen receptor biology, treatment options, and future directions.
|
|
Academic Article
|
Targeting aromatase and estrogen signaling in human non-small cell lung cancer.
|
|
Academic Article
|
Progesterone receptor (PR) polyproline domain (PPD) mediates inhibition of epidermal growth factor receptor (EGFR) signaling in non-small cell lung cancer cells.
|
|
Academic Article
|
Receptors for Insulin-Like Growth Factor-2 and Androgens as Therapeutic Targets in Triple-Negative Breast Cancer.
|
|
Academic Article
|
Extranuclear signaling by sex steroid receptors and clinical implications in breast cancer.
|
|
Academic Article
|
Progesterone Receptor Signaling in the Breast Tumor Microenvironment.
|
|
Academic Article
|
The effect of HER-2/neu overexpression on chemotherapeutic drug sensitivity in human breast and ovarian cancer cells.
|
|
Academic Article
|
Epidermal growth factor receptor and tyrosine phosphorylation of estrogen receptor.
|
|
Academic Article
|
Squalamine and cisplatin block angiogenesis and growth of human ovarian cancer cells with or without HER-2 gene overexpression.
|
|
Academic Article
|
Targeted therapy: wave of the future.
|
|
Academic Article
|
Antiangiogenic Steroids in Human Cancer Therapy.
|
|
Academic Article
|
Estrogen and growth factor receptor interactions in human breast and non-small cell lung cancer cells.
|
|
Academic Article
|
New approaches to reverse resistance to hormonal therapy in human breast cancer.
|
|
Academic Article
|
Aromatase expression predicts survival in women with early-stage non small cell lung cancer.
|
|
Academic Article
|
Estrogen-signaling pathways in lung cancer.
|
|
Academic Article
|
Expression levels of estrogen receptor beta in conjunction with aromatase predict survival in non-small cell lung cancer.
|
|
Academic Article
|
Progesterone and estrogen receptor expression and activity in human non-small cell lung cancer.
|
|
Academic Article
|
Antiestrogen fulvestrant enhances the antiproliferative effects of epidermal growth factor receptor inhibitors in human non-small-cell lung cancer.
|
|
Academic Article
|
The role of estrogen, progesterone and aromatase in human non-small-cell lung cancer.
|
|
Academic Article
|
Biologic roles of estrogen receptor-ß and insulin-like growth factor-2 in triple-negative breast cancer.
|
|
Academic Article
|
Ribonucleotide reductase subunit M2 predicts survival in subgroups of patients with non-small cell lung carcinoma: effects of gender and smoking status.
|
|
Academic Article
|
CD24 Expression and differential resistance to chemotherapy in triple-negative breast cancer.
|
|
Academic Article
|
Antiestrogens in combination with immune checkpoint inhibitors in breast cancer immunotherapy.
|
|
Academic Article
|
The combination of green tea and tamoxifen is effective against breast cancer.
|
|
Academic Article
|
Cathepsin D in breast cancer.
|
|
Academic Article
|
Biologic basis of sequential and combination therapies for hormone-responsive breast cancer.
|
|
Academic Article
|
Heritable membrane alterations and growth associated with enhanced leupeptin-sensitive proteinase activity in epithelial cells exposed to dibutylnitrosamine in vitro.
|
|
Academic Article
|
Estrogen receptor signaling pathways in human non-small cell lung cancer.
|
|
Academic Article
|
Estrogen Receptor-ß and the Insulin-Like Growth Factor Axis as Potential Therapeutic Targets for Triple-Negative Breast Cancer.
|
|
Academic Article
|
Elevated serum cathepsin B1-like activity in women with neoplastic disease.
|
|
Academic Article
|
Randomized phase II study of fulvestrant and erlotinib compared with erlotinib alone in patients with advanced or metastatic non-small cell lung cancer.
|
|
Academic Article
|
Estrogen receptor-beta is a potential target for triple negative breast cancer treatment.
|
|
Academic Article
|
Bovine HDL and Dual Domain HDL-Mimetic Peptides Inhibit Tumor Development in Mice.
|
|
Concept
|
Antibodies, Neoplasm
|
|
Concept
|
Breast Neoplasms
|
|
Concept
|
Uterine Cervical Neoplasms
|
|
Concept
|
Neoplasm Metastasis
|
|
Concept
|
Neoplasms, Experimental
|
|
Concept
|
Ovarian Neoplasms
|
|
Concept
|
Biomarkers, Tumor
|
|
Concept
|
Tumor Stem Cell Assay
|
|
Concept
|
Genital Neoplasms, Female
|
|
Concept
|
DNA, Neoplasm
|
|
Concept
|
Neoplasm Transplantation
|
|
Concept
|
Neoplasms, Hormone-Dependent
|
|
Concept
|
Tumor Cells, Cultured
|
|
Concept
|
Tumor Suppressor Proteins
|
|
Concept
|
Lung Neoplasms
|
|
Concept
|
Drug Resistance, Neoplasm
|
|
Concept
|
Neoplasm Staging
|
|
Concept
|
Cell Line, Tumor
|
|
Concept
|
Tumor Burden
|
|
Concept
|
Vaginal Neoplasms
|
|
Concept
|
Lymphocytes, Tumor-Infiltrating
|
|
Concept
|
Neoplasm Proteins
|
|
Concept
|
Neoplasms
|
|
Concept
|
Tumor Microenvironment
|
|
Concept
|
Triple Negative Breast Neoplasms
|
|
Academic Article
|
Squalamines in Blockade of Tumor-Associated Angiogenesis and Cancer Progression.
|
|
Academic Article
|
Sex steroid hormones and DNA repair regulation: Implications on cancer treatment responses.
|